What is the importance of classifying Aspergillus disease in cystic fibrosis patients?

Expert Review of Respiratory Medicine

Volumn 8, Issue 4, 2014, Pages 389-392

  Jones, Andrew M ^a   Horsley, Alex ^a   Denning, David W ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergillus bronchitis; Cystic fibrosis Aspergillus; Galactomannan; IgE; IgG; PCR; Triazoles

Indexed keywords

ANTIFUNGAL AGENT; GLIOTOXIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 5; ITRACONAZOLE; MOLECULAR MARKER; POSACONAZOLE; TRIAZOLE; TRIAZOLE DERIVATIVE; VITAMIN D RECEPTOR; VORICONAZOLE;

ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS; BURKHOLDERIA CENOCEPACIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; GENETIC PREDISPOSITION; HAEMOPHILUS INFLUENZAE; HUMAN; NONHUMAN; PATIENT; PHENOTYPE; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SENSITIZATION; STAPHYLOCOCCUS AUREUS; COMPLICATION; ISOLATION AND PURIFICATION; LUNG; LUNG ASPERGILLOSIS; MICROBIOLOGY;

ASPERGILLUS; CYSTIC FIBROSIS; HUMANS; LUNG; PULMONARY ASPERGILLOSIS;

EID: 84904360978     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2014.915751     Document Type: Review

References (22)

1. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003;37(Suppl 3):S225-64
2. Shoseyov D, Brownlee KG, Conway SP, Kerem E. Aspergillus bronchitis in cystic fibrosis. Chest 2006;130(1): 222-6
3. De Boer K, Vandemheen KL, Tullis E, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax 2011;66(8): 680-5
4. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in cystic fibrosis patients. Chest 2010;137(1): 171-6
5. Baxter CG, Moore CB, Jones AM, et al. IgE mediated immune responses and airway detection of Aspergillus and Candida in adults with cystic fibrosis. Chest 2013;143: 1351-7
6. McMahon MA, Chotirmall SH, McCullagh B, et al. Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. Eur J Radiol 2012;81(3): 197-202
7. de Vrankrijker AM, van der Ent CK, van Berkhout FT, et al. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? Clin Microbiol Infect 2010;17: 1381-6
8. Chrdle A, Mustakim S, Bright-Thomas R, et al. Aspergillus bronchitis in non-immunocompromised patients - case series, response to treatment and criteria for diagnosis. Ann N Y Acad Sci 2012;1272: 73-85
9. Fairs A, Agbetile J, Hargadon B, et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010;182: 1362-8
10. Agbetile J, Fairs A, Desai D, et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy 2012;42: 782-91
11. Nagano Y, Elborn JS, Millar BC. Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis. Med Mycol 2010;48(1): 166-76
12. Pashley CH, Fairs A, Morley JP, et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol 2012;50: 433-8
13. Baxter CG, Denning DW, Jones AM, et al. Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. Clin Microbiol Infect 2013;19:E197-204
14. Baxter C, Jones A, Webb K, Denning D. Homogenisation of cystic fibrosis sputum by sonication - an essential step for Aspergillus PCR. J Microbiol. Methods 2011;85: 75-81
15. Latzin P, Hartl D, Regamey N, et al. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 2007;68(7): 652-7
16. Elphick HE, Southern KW. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev 2012;6: CD002204
17. Aaron SD, Vandemheen KL, Freitag A, et al. Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study. PLoS One 2012;7(4):e36077
18. Coughlan CA, Chotirmall SH, Renwick J, et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am J Respir Crit Care Med 2012;186: 999-1007
19. Baxter CG, Rautemaa R, Jones AM, et al. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum. Thorax 2013;68(7): 652-7
20. Knutsen AP, Bush R, Demain JD, et al. Fungi and allergic respiratory diseases. J Allergy Clin Immunol 2012;129: 280-91
21. Mueller C, Braag SA, Keeler A, et al. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol 2011;44: 922-9
22. Baxter CG, Dunn G, Jones AM, et al. Classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol 2013;132: 560-6